Proof-of-concept visualization of CXCR4 expression with the recently developed CXCR4-directed PET tracer [68Ga]Pentixafor has been shown in hematologic malignancies, small cell lung cancer and glioblastoma [1–6]. The gene discussed is CXCR4; the disease is hematologic disorder.